Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Therapeutic potential of selenium compounds in the treatment of cancer
Arun Kumar Selvam
, Mikael Björnstedt
, Sougat Misra
Veterinary and Biomedical Sciences
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
4
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapeutic potential of selenium compounds in the treatment of cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Treatment
100%
Therapeutic Potential
100%
Selenium Compounds
100%
Cytotoxic Effect
75%
Sodium Selenite
75%
Methylselenocysteine
75%
Cancer Chemotherapeutics
50%
Small Molecules
25%
Oral Administration
25%
Clinical Setting
25%
Safety Profile
25%
Mechanism of Action
25%
Methylselenol
25%
Clinical Translation
25%
Intracellular Signaling
25%
Active Area
25%
Antiproliferative Activity
25%
Pharmacokinetic Profile
25%
Tumor-specific
25%
Cancer Chemotherapeutic Agents
25%
Redox Cycle
25%
Antiproliferative Efficacy
25%
Phase I Clinical Trial
25%
Chemotherapy Efficacy
25%
Cancer Drug Discovery
25%
Cellular Thiols
25%
Metabolic Transformation
25%
In Vitro Tumor Models
25%
Enzymatic Transformation
25%
Antineoplastic Efficacy
25%
Free Thiols
25%
Cellular Redox Status
25%
Medicine and Dentistry
Malignant Neoplasm
100%
Cancer Treatment
100%
Selenium Derivative
100%
Cytotoxicity
60%
Sodium Selenite
60%
Chemotherapy
60%
Thiol
40%
Pharmacokinetics
20%
Clinical Trial
20%
Oral Drug Administration
20%
Cell Signaling Pathway
20%
Intracellular Signaling
20%
Antiproliferative Activity
20%
Specific Tumor
20%
Toxicity
20%
Chemistry
Selenium
100%
Sodium
75%
Se-Methylselenocysteine
75%
Antiproliferative
50%
Thiol
50%
Pool
25%
Toxic
25%
Pharmacokinetics
25%
Metabolic
25%
Drug Discovery
25%
Cancer Drug
25%
Methylselenol
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Selenium Compound
100%
Sodium Selenite
50%
Cytotoxicity
33%
Thiol
33%
Drug Discovery
16%
Neoplasm
16%
Clinical Trial
16%
Normal Human
16%
Toxicity
16%
Pharmacokinetics
16%
Immunology and Microbiology
Cytotoxicity
100%
Normal Human
33%
Intracellular Signaling
33%
Antiproliferative Activity
33%
Pharmacokinetics
33%
Oxidation Reduction Reaction
33%